IA
YTEN

IFP Advisors’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

IFP Advisors’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$7 – 3262
2023
Q4 		$7 Hold
1
– – ﹤0.01% 3025
2023
Q3 		$10 Hold
1
– – ﹤0.01% 3272
2023
Q2 		$67 Hold
1
– – ﹤0.01% 3371
2023
Q1 		$188 Hold
1
– – ﹤0.01% 3278
2022
Q4 		$1K Hold
1
– – ﹤0.01% 4546
2022
Q3 		$1K Hold
1
– – ﹤0.01% 4732
2022
Q2 		$1K Hold
1
– – ﹤0.01% 4499
2022
Q1 		$1K Buy
+1
New +$103 ﹤0.01% 4497
2019
Q1 		– Hold
0
– – – 3570
2018
Q4 		– Hold
0
– – – 3924
2018
Q3 		– Hold
0
– – – 4054
2018
Q2 		– Hold
0
– – – 4098
2018
Q1 		– Hold
0
– – – 3852
2017
Q4 		– Hold
0
– – – 4153
2017
Q3 		– Hold
0
– – – 4244
2017
Q2 		– Hold
0
– – – 4246
2017
Q1 		– Hold
0
– – – 4162
2016
Q4 		– Hold
0
– – – 4167
2016
Q3 		– Hold
0
– – – 4078
2016
Q2 		– Hold
0
– – – 4117
2016
Q1 		– Hold
0
– -$1K – 3557
2015
Q4 		– Hold
0
– – – 3594

Other funds holding YTEN

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GWM
Grand Wealth Management Grand Rapids, Michigan $212M AUM 18.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

IFP Advisors's YTEN Position: Q1 2024 in Review

IFP Advisors sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q1 2024, closing a stake of 1 share — an estimated $7 sold.

IFP Advisors first reported a position in YTEN in Q1 2022 and held it in 8 quarters. The position peaked at $1K in Q4 2022. 19 funds tracked by Wall St. Rank hold YTEN as of Q1 2024.

  • IFP Advisors reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • IFP Advisors sold 1 Yield10 Bioscience, Inc. Common Stock share in Q1 2024, an estimated $7.
  • IFP Advisors first reported a position in Yield10 Bioscience, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
  • IFP Advisors's Yield10 Bioscience, Inc. Common Stock position peaked at $1K in Q4 2022.
  • 19 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q1 2024.

Based on IFP Advisors's 13F filing for Q1 2024, filed 30 Jul 2024.